Inactive Instrument
BSF Enterprise Plc Stock OTC Markets
Stocks
BSFA.F
GB00BHNBDQ51
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.42M 1.9M 1.66M 1.53M 2.7M 181M 2.74M 18.31M 7.12M 88.86M 7.13M 6.97M 306M | P/E 2024 |
-2.47x | P/E 2025 | -3.56x |
|---|---|---|---|---|---|
| Enterprise Value | 1.27M 1.7M 1.49M 1.37M 2.41M 162M 2.45M 16.39M 6.37M 79.55M 6.38M 6.24M 274M | EV / Sales 2024 |
61,809,222x | EV / Sales 2025 | 76,138,323x |
| Free-Float |
80.4% | Yield 2024 * |
-
| Yield 2025 | - |
| 02-06 | BSF : Proxy Form | PU |
| 02-06 | BSF : Notice of AGM | PU |
| 25-03-06 | BSF : Publication of Prospectus | PU |
| 25-03-06 | BSF : Prospectus | PU |
| 25-02-07 | BSF : Proxy Form | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Che Connon
CEO | Chief Executive Officer | 54 | - |
Graham Duncan
DFI | Director of Finance/CFO | 63 | 2022-06-05 |
Ricardo Gouveia
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Geoffrey Baker
CHM | Chairman | 70 | 2025-12-04 |
Kian Jing Ow
BRD | Director/Board Member | 60 | 2021-08-04 |
Che Connon
BRD | Director/Board Member | 54 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.9M | |
| +4.73% | +3.38% | +19.53% | -8.89% | 66.56B | |
| -1.93% | +0.39% | +53.64% | +226.01% | 56.51B | |
| +1.07% | +42.10% | +42.10% | +42.10% | 42.98B | |
| +3.45% | +6.04% | -49.82% | -55.95% | 40.46B | |
| +3.04% | +0.04% | +62.66% | -24.29% | 31.91B | |
| +10.01% | +18.57% | +161.59% | -34.48% | 31.65B | |
| +2.68% | +2.73% | +70.72% | +88.24% | 23.35B | |
| +2.87% | +16.83% | +1.86% | +165.26% | 19.46B | |
| -0.13% | +2.75% | +66.32% | +127.01% | 17.18B | |
| Average | +2.58% | +8.76% | +47.62% | +58.33% | 36.67B | |
| Weighted average by Cap. | +2.79% | +7.31% | +42.61% | +52.47% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.06 0.08 0.07 0.06 0.11 7.35 0.11 0.74 0.29 3.61 0.29 0.28 12.45 | 0.05 0.07 0.06 0.06 0.1 6.72 0.1 0.68 0.26 3.3 0.26 0.26 11.38 |
| Net income | -1.67M -2.23M -1.95M -1.79M -3.17M -213M -3.22M -21.54M -8.37M -105M -8.38M -8.2M -360M | -1.11M -1.49M -1.3M -1.19M -2.11M -142M -2.14M -14.34M -5.58M -69.59M -5.58M -5.46M -240M |
| Net Debt | -560K -747K -653K -600K -1.06M -71.15M -1.08M -7.21M -2.8M -34.98M -2.81M -2.74M -121M | -149K -199K -174K -160K -283K -18.95M -287K -1.92M -746K -9.31M -747K -731K -32.09M |
Employees
14
Sector
Pharmaceuticals
